The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond

Recent years have brought major advancements in the use of immune therapy and specifically immune checkpoint inhibitors (ICIs) in cancer patients, with expanding indications for various malignancies resulting in the treatment of a large and increasing number of patients. While this therapy significa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilon, Dan, Iakobishvili, Zaza, Leibowitz, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879796/
https://www.ncbi.nlm.nih.gov/pubmed/35214762
http://dx.doi.org/10.3390/vaccines10020304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879796/
https://www.ncbi.nlm.nih.gov/pubmed/35214762
http://dx.doi.org/10.3390/vaccines10020304

Ejemplares similares